Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify Tumor Draining Lymph Nodes in Early-stage Lung Cancer

NCT05555199 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05555199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05555199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify Tumor Draining Lymph Nodes in Early-stage Lung Cancer
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
October 3, 2022
Completion date
October 31, 2024
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage lung cancer